N4 Pharma
N4 Pharma is a pre-clinical stage pharmaceutical company developing Nuvec, a silica nanoparticle technology designed to load, protect, and deliver nucleic acids for gene therapy, cancer therapeutics, and vaccines. Established in 2014 and listed on the AIM stock market in May 2017, the company focuses on addressing the limitations of existing delivery systems.
- Cancer therapeutics
- Vaccine development
- Gene therapy solutions
- Nuvec technology for nucleic acid delivery
Locations
Company Details
N4 Pharma is operated by N4 Pharma UK Limited and is a Active company incorporated on 5 February 2014 with the registered office located in Derby, Derbyshire. N4 Pharma UK Limited was registered 11 years ago.
Status
Active
Size
Micro
Directors
2
Age
11 years old
Employees
2
Turnover
Unreported
Total Assets
£147.51K
Cash in Bank
£45.92K
Total Liabilities
-£8.44M